Living Cell Technologies
Living Cell Technologies (LCT) has developed technologies for transplanting healthy cells into people to replace or repair damaged organs.
They are using this technology to develop treatments for type I diabetes, Huntington’s disease, stroke, hearing loss and haemophilia.
LCT uses pig cells that are coated in a protective gel made from an extract of seaweed. The protective coating prevents the animal cells from being attacked by the patient’s immune system. Therefore, patients receiving treatment with these cells do not need to take toxic, immunosuppressive drugs.
In 2007, LCT started a human clinical trial using pig cells to treat people with type I diabetes.
- 07 November 2007